RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients

Authors :: Amparo Macías
M. Hernandez
Elia Neninger
Anet Valdes
Yoana Flores
Ivis Mendoza
Rosa Maria Amador
Ramón Ortiz
Eduardo Santiesteban
Mayte Robaina
Tania Crombet
Ana María Vázquez
Soraida Acosta
Pedro Pablo Guerra
Source :: Journal of Clinical Oncology. 32:TPS3111-TPS3111
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: TPS3111 Background: Despite extensive research in NSCLC treatment, overall survival remains insufficient. Immunotherapy has become a viable treatment to help the immune system to control or elimina...

Full Text Access

Tools